APP and neurodegenerative disease: DAPK1 regulates its downstream targets, such as tau, amyloid precursor protein, α-synuclein, and NR2B, as it serves mostly as a direct kinase in the development of neurodegenerative diseases, suggesting that DAPK1 might be a central regulator in these diseases.